Longeveron Stock: Speculative Biotech Worth A Look (NASDAQ: LGVN)
Longeveron obtained Rare Pediatric Designation of Lomecel-B for patients with HLHS. Here's why LGVN stock is worth a look as a speculative buy.
Source: seekingalpha.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Doing Research. Real-time updates on events, politics, business and more.